Evidence for a prosurvival role of alpha-7 nicotinic acetylcholine receptor in alternatively (M2)-activated macrophages

Physiological Reports

Volumn 1, Issue 7, 2013, Pages

  Lee, Robert H ^a   Vazquez, Guillermo ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Macrophage polarization; Macrophage survival; 7 nicotinic acetylcholine receptor

Indexed keywords

4 CHLORO N (3 QUINUCLIDINYL)BENZAMIDE; BUNGAROTOXIN RECEPTOR; CHOLESTEROL; JANUS KINASE 2; NICOTINIC AGENT; STAT PROTEIN; STAT3 PROTEIN; THAPSIGARGIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL SURVIVAL; CONTROLLED STUDY; CYTOLYSIS; ENDOTHELIUM CELL; GENE ACTIVATION; GENE EXPRESSION; IMMUNOBLOTTING; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; STRESS; TUNEL ASSAY;

EID: 85008951034     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.1002/phy2.189     Document Type: Article

References (45)

1. Akaike, A., Y. Takada-Takatori, T. Kume, and Y. Izumi. 2010. Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection. J. Mol. Neurosci. 40: 211-216.
2. Albuquerque, E. X., E. F. R. Pereira, M. Alkondon, and S. W. Rogers. 2009. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol. Rev. 89: 73-120.
3. Barrantes, F., V. Bermudez, M. Borroni, S. Antollini, M. Pediconi, J. Baier, et al. 2010. Boundary lipids in the nicotinic acetylcholine receptor microenvironment. J. Mol. Neurosci. 40:87-90.
4. Bodnar, A., L. A. Cortes-Burgos, K. K. Cook, D. M. Dinh, V. E. Groppi, M. Hajos, et al. 2005. Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors. J. Med. Chem. 48:905-908.
5. Bray, C., J.-H. Son, and S. Meizel. 2005. Acetylcholine causes an increase of intracellular calcium in human sperm. Mol. Hum. Reprod. 11:881-889.
6. Cheng, F., H. Wang, P. Horna, Z. Wang, B. Shah, E. Sahakian, et al. 2012. Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunity. Cancer Res. 72:4440-4448.
7. De Rosa, M. J., L. Dionisio, E. Agriello, C. Bouzat, and M. D. C. Esandi. 2009. Alpha 7 nicotinic acetylcholine receptor modulates lymphocyte activation. Life Sci. 85: 444-449.
8. De Simone, R., M. A. Ajmone-Cat, D. Carnevale, and L. Minghetti. 2005. Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures. J. Neuroinflammation 2:4.
9. Gubbins, E. J., M. Gopalakrishnan, and J. Li. 2010. Alpha7 nAChR-mediated activation of MAP kinase pathways in PC12 cells. Brain Res. 1328:1-11.
10. Hecker, A., Z. Mikulski, K. S. Lips, U. Pfeil, A. Zakrzewicz, S. Wilker, et al. 2009. Pivotal advance: up-regulation of acetylcholine synthesis and paracrine cholinergic signaling in intravascular transplant leukocytes during rejection of rat renal allografts. J. Leukoc. Biol. 86:13-22.
11. de Jonge, W. J. and L. Ulloa. 2007. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br. J. Pharmacol. 151:915-929.
12. de Jonge, W. J., E. P. van der Zanden, F. O. The, M. F. Bijlsma, D. J. van Westerloo, R. J. Bennink, et al. 2005. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat. Immunol. 6:844-851.
13. Kawashima, K., K. Yoshikawa, Y. X. Fujii, Y. Moriwaki, and H. Misawa. 2007. Expression and function of genes encoding cholinergic components in murine immune cells. Life Sci. 80:2314-2319.
14. Khallou-Laschet, J., A. Varthaman, G. Fornasa, C. Compain, A.-T. Gaston, M. Clement, et al. 2010a. Macrophage plasticity in experimental atherosclerosis. PLoS ONE 5: e8852.
15. Khallou-Laschet, J., A. Varthaman, G. Fornasa, C. Compain, A. T. Gaston, M. Clement, et al. 2010b. Macrophage plasticity in experimental atherosclerosis. PLoS ONE 5: e8852.
16. Korns, D., S. C. Frasch, R. Fernandez-Boyanapalli, P. M. Henson, and D. L. Bratton. 2011. Modulation of macrophage efferocytosis in inflammation. Front. Immunol. 2:57.
17. Lee, C. W., I. Hwang, C.-S. Park, H. Lee, D.-W. Park, S.-J. Kang, et al. 2013. Macrophage heterogeneity of culprit coronary plaques in patients with acute myocardial infarction or stable angina. Am. J. Clin. Pathol. 139:317-322.
18. Ley, K., Y. I. Miller, and C. C. Hedrick. 2011. Monocyte and macrophage dynamics during atherogenesis. Arterioscler. Thromb. Vasc. Biol. 31:1506-1516.
19. Li, Y., Y. Zhang, B. Dorweiler, D. Cui, T. Wang, C. W. Woo, et al. 2008. Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism. J. Biol. Chem. 283:34833-34843.
20. Liu, H., Y. Ma, S. M. Cole, C. Zander, K. H. Chen, J. Karras, et al. 2003. Serine phosphorylation of STAT3 is essential for Mcl-1 expression and macrophage survival. Blood 102:344-352.
21. Mallavia, B., C. Recio, A. Oguiza, G. Ortiz-Munoz, I. Lazaro, V. Lopez-Parra, et al. 2013. Peptide inhibitor of NF-kB translocation ameliorates experimental atherosclerosis. Am. J. Pathol. 182:1910-1921.
22. Mantovani, A., C. Garlanda, and M. Locati. 2009. Macrophage diversity and polarization in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29:1419-1423.
23. Marrero, M. B. and M. Bencherif. 2009. Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-kappaB. Brain Res. 1256:1-7.
24. Marrero, M., M. Bencherif, P. Lippiello, and R. Lucas. 2011. Application of alpha7 nicotinic acetylcholine receptor agonists in inflammatory diseases: an overview. Pharm. Res. 28:413-416.
25. Martinez, F. O., A. Sica, A. Mantovani, and M. Locati. 2008. Macrophage activation and polarization. Front. Biosci. 13:453-461.
26. Nai, Q., J. M. McIntosh, and J. F. Margiotta. 2003. Relating neuronal nicotinic acetylcholine receptor subtypes defined by subunit composition and channel function. Mol. Pharmacol. 63:311-324.
27. Oyadomari, S. and M. Mori. 2004. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 11:381-389.
28. Scull, C. M. and I. Tabas. 2011. Mechanisms of ER stress-induced apoptosis in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 31:2792-2797.
29. Seimon, T. and I. Tabas. 2009. Mechanisms and consequences of macrophage apoptosis in atherosclerosis. J. Lipid Res. 50 (Suppl.):S382-S387.
30. Shen, J.-X. and J. L. Yakel. 2009. Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system. Acta Pharmacol. Sin. 30:673-680.
31. Skok, M. 2009. To channel or not to channel? Functioning of nicotinic acetylcholine receptors in leukocytes. J. Leukoc. Biol. 86:1-3.
32. Smedlund, K., J. Y. Tano, J. Margiotta, and G. Vazquez. 2011. Evidence for operation of nicotinic and muscarinic acetylcholine receptor-dependent survival pathways in human coronary artery endothelial cells. J. Cell. Biochem. 112:1978-1984.
33. Spandidos, A., X. Wang, H. Wang, and B. Seed. 2010. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res. 38:D792-D799.
34. Su, X., J. W. Lee, Z. A. Matthay, G. Mednick, T. Uchida, X. Fang, et al. 2007. Activation of the alpha7 nAChR reduces acid-induced acute lung injury in mice and rats. Am. J. Respir. Cell Mol. Biol. 37:186-192.
35. Tabas, I. 2009. Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress. Antioxid. Redox Signal. 11:2333-2339.
36. Tabas, I. 2010. Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10:36-46.
37. Tano, J.-Y. and G. Vazquez. 2011. Requirement for non-regulated, constitutive calcium influx in macrophage survival signaling. Biochem. Biophys. Res. Commun. 407:432-437.
38. Tano, J.-Y., S. Solanki, R. H. Lee, K. Smedlund, L. Birnbaumer, and G. Vazquez. 2013. Bone marrow deficiency of trpc3 channel reduces early lesion burden and necrotic core of advanced plaques in a mouse model of atherosclerosis. Cardiovasc. Res. [Epub ahead of print]
39. Tano, J.-Y., K. Smedlund, R. Lee, J. Abramowitz, L. Birnbaumer, and G. Vazquez. 2011. Impairment of survival signaling and efferocytosis in TRPC3-deficient macrophages. Biochem. Biophys. Res. Commun. 410:643-647.
40. Tano, J.-Y., R. H. Lee, and G. Vazquez. 2012a. Involvement of calmodulin and calmodulin kinase II in tumor necrosis factor alpha-induced survival of bone marrow derived macrophages. Biochem. Biophys. Res. Commun. 427:178-184.
41. Tano, J. Y., R. H. Lee, and G. Vazquez. 2012b. Macrophage function in atherosclerosis: potential roles of TRP channels. Channels (Austin) 6:141-148.
42. Tsukano, H., T. Gotoh, M. Endo, K. Miyata, H. Tazume, T. Kadomatsu, et al. 2010. The endoplasmic reticulum stress-C/EBP homologous protein pathway-mediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 30:1925-1932.
43. Wang, X., A. Spandidos, H. Wang, and B. Seed. 2012. PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update. Nucleic Acids Res. 40: D1144-D1149.
44. Wang, H., M. Yu, M. Ochani, C. A. Amella, M. Tanovic, S. Susarla, et al. 2003. Nicotinic acetylcholine receptor [alpha]7 subunit is an essential regulator of inflammation. Nature 421:384-388.
45. Wilund, K. R., M. Rosenblat, H. R. Chung, N. Volkova, M. Kaplan, J. A. Woods, et al. 2009. Macrophages from alpha 7 nicotinic acetylcholine receptor knockout mice demonstrate increased cholesterol accumulation and decreased cellular paraoxonase expression: a possible link between the nervous system and atherosclerosis development. Biochem. Biophys. Res. Commun. 390:148-154.